Previous 10 | Next 10 |
The clinical-stage biotechnology company Longeveron (NASDAQ:LGVN) has lost ~10% in the pre-market Friday after the company signaled a potential delay for results from its Aging Frailty trial for the lead candidate, Lomecel-B. The data from the Phase 1/2 trial called “HERA...
Orphazyme (NASDAQ:ORPH) -39% on commencement of in-court restructuring. Tilly's (NYSE:TLYS) -25% on Q4 earnings release. AgriFORCE Growing Systems (NASDAQ:AGRI) -18%. DocuSign (NASDAQ:DOCU) -16% on Q4 earnings release. Sunworks (NASDAQ:SUNW) -15% o...
Longeveron press release (NASDAQ:LGVN): Q4 GAAP EPS of -$0.20 beats by $0.05. Revenue of $0.21M (-82.2% Y/Y). CEO comment: “Since our IPO in February of last year, important progress has been made in advancing Lomecel-B into next phase trials, including initiation of Phase 2 trials in ...
Currently Enrolling Clinical Trials with Lomecel-B in Three Disease Indications: Hypoplastic Left Heart Syndrome (Phase 2a), Alzheimer’s Disease (Phase 2a), and Covid-related Acute Respiratory Distress Syndrome (Phase 1) Lomecel-B for HLHS Granted Rare Pediatric Disease a...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Amazon (NASDAQ: AMZN ) stock is on the move Thursday after the e-commerce giant announced a stock split taking place this year alongside a $10 billion share buyback. Source: Frederic Legrand – COMEO / Shutt...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors will remember Longeveron (NASDAQ: LGVN ) as a late 2021 meme stock. The biopharmaceutical company briefly shot to market prominence in late November 2021 before beginning a gradual decline. LGVN stock has sp...
Gainers: Kala Pharmaceuticals (NASDAQ:KALA) +20%. Natera (NASDAQ:NTRA) +17%. Chemomab Therapeutics (NASDAQ:CMMB) +13%. Selecta Biosciences (NASDAQ:SELB) +11%. Longeveron (NASDAQ:LGVN) +7%. Losers: Sunshine Biopharma (NASDAQ:SBFM) -32%. My...
Enservco (NYSE:ENSV) +32%. Indonesia Energy (NYSE:INDO) +30% mobilizes drilling rig to commence drilling of two back-to-back production wells at Kruh block. Houston American Energy (NYSE:HUSA) +15%. TMC the metals company (NASDAQ:TMC) +15%. Longeveron (NASDAQ:LGVN) +15% ahead o...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re preparing for another busy day of trading with the biggest pre-market stock movers for Thursday! Source: oneinchpunch/Shutterstock.com Penny stocks continue to see heavy volatility...
The shares of Longeveron (LGVN +35.0%) a clinical-stage biotechnology company focused on cellular therapies have risen sharply on Wednesday ahead of its Q4 2021 results scheduled for tomorrow before the market open. Currently, approximately 1.7 million Longeveron (NASDAQ:LGVN) shares have cha...
News, Short Squeeze, Breakout and More Instantly...
Longeveron (NASDAQ: LGVN) , a clinical-stage, regenerative-medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions, has closed on its previously announced registered direct offering. The offering, which was priced at-the-market ...
MIAMI, July 19, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today ann...
A look at the top 10 most actives in the United States Onconetix Inc. (ONCO) rose 113.3% to $0.3178 on volume of 162,323,665 shares NVIDIA Corporation (NVDA) rose 0.8% to $118.92 on volume of 44,858,282 shares Maxeon Solar Technologies Ltd. (MAXN) rose 8.5% to $0.2648 on volume of 43,008,...